Atlas Trials

Connectomic Targeted TMS Target for Refractory Anxiety

Clinical trial NCT06376877 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06376877
Sponsor
Brigham and Women's Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety DisordersMental DisorderPsychiatric Disorder
Start date
2024-08-01
Primary completion
2028-08-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.